Analysts Slash FICO Target, Lift Regeneron

Wall Street made two sharp calls on Monday, cutting price targets on Fair Isaac Corporation while raising them on Regeneron Pharmaceuticals.

The consensus target on FICO fell to $897 from $937. That is a $40 drop in a single session. The stock carries short interest of 11.6% of free float, one of the higher readings among large-cap tech names. Analysts are cooling on the credit-scoring group after a run that took valuation to stretched levels.

Regeneron saw the opposite treatment. The consensus target jumped to $962 from $924, a $38 move higher. The pharma group has been among the more actively covered names on the Street, with 19 buy ratings in the current consensus.

Advanced Micro Devices also attracted upward revisions. The consensus target edged to $646 from $640, with 43 buy ratings out of 53 analysts. The energy sector drew broad upgrades too. Valero Energy, ExxonMobil, and Chevron all saw consensus targets lifted on the same day, suggesting analysts are re-rating the group after recent oil price moves.

Take-Two Interactive saw its target rise to $287 from $285 ahead of its next earnings cycle, while Colgate-Palmolive and Church & Dwight received modest target increases in the consumer staples space.